XaTek, founded in 2016 and based in Cleveland, Ohio, is a biomedical device company focused on addressing urgent healthcare needs. The company's core mission is to make clinical evaluation of whole-blood coagulation more accessible at the point of care. XaTek's flagship product, ClotChip®, utilizes dielectric spectroscopy to provide rapid and accurate assessments of blood coagulation, regardless of the underlying cause. This innovation aims to improve patient outcomes in critical care settings.
XaTek is led by a team of experienced inventors, entrepreneurs, and market innovators with a proven track record in the medical device industry. The company has garnered attention for its groundbreaking technology and has participated in various clinical trials to validate its efficacy. XaTek's impact is marked by its potential to revolutionize point-of-care diagnostics, making life-saving information readily available to healthcare providers when it matters most.
